{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T06:01:10Z","timestamp":1742796070020,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["21ck0106717h0001"],"award-info":[{"award-number":["21ck0106717h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12185-024-03892-z","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:38:05Z","timestamp":1733287085000},"page":"252-256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dexamethasone palmitate for children with Epstein-Barr virus associated hemophagocytic lymphohistiocytosis"],"prefix":"10.1007","volume":"121","author":[{"given":"Rintaro","family":"Ono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1499-538X","authenticated-orcid":false,"given":"Kenichi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryu","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Kanegane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yozo","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Shioda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the HLH\/LCH committee members of the Japan Children\u2019s Cancer Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"3892_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1532\/IJH97.07012","volume":"86","author":"E Ishii","year":"2007","unstructured":"Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86:58\u201365. https:\/\/doi.org\/10.1532\/IJH97.07012.","journal-title":"Int J Hematol"},{"key":"3892_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/s1040-8428(02)00117-8","volume":"44","author":"S Imashuku","year":"2002","unstructured":"Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol. 2002;44:259\u201372. https:\/\/doi.org\/10.1016\/s1040-8428(02)00117-8.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3892_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fped.2016.00047","volume":"13","author":"E Ishii","year":"2016","unstructured":"Ishii E. Hemophagocytic lymphohistiocytosis in children: pathogenesis and treatment. Front Pediatr. 2016;13:4\u201347. https:\/\/doi.org\/10.3389\/fped.2016.00047.","journal-title":"Front Pediatr"},{"key":"3892_CR4","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1182\/blood.2021014860","volume":"16","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Zhao YZ, Ma HH, Wang D, Cui L, Li WJ, et al. A study of ruxolitinib response-based stratified treatment for pediatric hemophagocytic lymphohistiocytosis. Blood. 2022;16:3493\u2013504. https:\/\/doi.org\/10.1182\/blood.2021014860.","journal-title":"Blood"},{"key":"3892_CR5","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1182\/blood.2019003886","volume":"135","author":"P Liu","year":"2020","unstructured":"Liu P, Pan X, Chen C, Niu T, Shuai X, Wang J, et al. Nivolumab treatment of relapsed\/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults. Blood. 2020;135:826\u201333. https:\/\/doi.org\/10.1182\/blood.2019003886.","journal-title":"Blood"},{"key":"3892_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/ard.41.3.263","volume":"41","author":"Y Mizushima","year":"1982","unstructured":"Mizushima Y, Hamano T, Yokoyama K. Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion. Ann Rheum Dis. 1982;41:263\u20137.","journal-title":"Ann Rheum Dis"},{"key":"3892_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12185-012-1023-z","volume":"95","author":"S Nishiwaki","year":"2012","unstructured":"Nishiwaki S, Nakayama T, Murata M, Nishida T, Sugimoto K, Saito S, et al. Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation: macrophage-targeted steroid therapy. Int J Hematol. 2012;95:428\u201333.","journal-title":"Int J Hematol"},{"key":"3892_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s12185-019-02659-1","volume":"110","author":"H Sugiura","year":"2019","unstructured":"Sugiura H, Matsuoka KI, Matsuda M, Ikegawa S, Inomata T, Kuroi T, et al. Macrophage elimination in bone marrow by dexamethasone palmitate is associated with successful engraftment in patients with hemophagocytic syndrome. Int J Hematol. 2019;110:260\u20132.","journal-title":"Int J Hematol"},{"key":"3892_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-023-02098-x","author":"R Ono","year":"2023","unstructured":"Ono R, Sakamoto K, Doi T, Yanagisawa R, Morimoto A, Kanegnae H, et al. Dexamethasone palmitate as an etoposide-free treatment for children with hemophagocytic lymphohistiocytosis after hematopoietic cell transplantation. Bone Marrow Transplant. 2023. https:\/\/doi.org\/10.1038\/s41409-023-02098-x. (Online ahead of print).","journal-title":"Bone Marrow Transplant"},{"key":"3892_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/ped.12817","volume":"58","author":"K Otsubo","year":"2016","unstructured":"Otsubo K, Fukumura A, Hirayama M, Morimoto T, Kato M, Mochizuki H. Hemophagocytic lymphohistiocytosis caused by systemic herpes simplex virus type 1 infection: successful treatment with dexamethasone palmitate. Pediatr Int. 2016;58:390\u20133.","journal-title":"Pediatr Int"},{"key":"3892_CR11","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/ped.13665","volume":"60","author":"D Tamura","year":"2018","unstructured":"Tamura D, Inoue S, Kawahara Y, Mori M, Yamagata T. Hypercytokinemia with hemophagocytic syndrome due to human metapneumovirus. Pediatr Int. 2018;60:974\u20136.","journal-title":"Pediatr Int"},{"key":"3892_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331. https:\/\/doi.org\/10.1002\/pbc.21039.","journal-title":"Pediatr Blood Cancer"},{"key":"3892_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2177\/jsci.39.190","volume":"39","author":"H Wakiguchi","year":"2016","unstructured":"Wakiguchi H, Ohga S. Clinical utility of the liposteroid therapy: potential effects on the macrophage activation. Nihon Rinsho Meneki Gakkai kaishi. 2016;39:190\u20136.","journal-title":"Nihon Rinsho Meneki Gakkai kaishi"},{"key":"3892_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s12185-018-02572-z","volume":"109","author":"R Yanagisawa","year":"2019","unstructured":"Yanagisawa R, Nakazawa Y, Matsuda K, Yasumi T, Kanegane H, Ohga S, et al. Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan. Int J Hematol. 2019;109:206\u201313.","journal-title":"Int J Hematol"},{"key":"3892_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/pbc.24039","volume":"59","author":"A Shiraishi","year":"2012","unstructured":"Shiraishi A, Ohga S, Doi T, Ishimura M, Takimoto T, Takada H, et al. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2012;59:265\u201370.","journal-title":"Pediatr Blood Cancer"},{"key":"3892_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s12185-022-03357-1","volume":"116","author":"R Ono","year":"2022","unstructured":"Ono R, Sakamoto K, Doi T, Yanagisawa R, Tamura A, et al. A retrospective survey of patients who discontinued participation in the JPLSG HLH-2004 clinical trial. Int J Hematol. 2022;116:434\u201341.","journal-title":"Int J Hematol"},{"key":"3892_CR17","first-page":"621","volume":"11","author":"K Hoshi","year":"1985","unstructured":"Hoshi K, Mizushima Y, Shiokawa Y, Kageyama T, Honma M, Kashiwazaki S, et al. Double-blind study with liposteroid in rheumatoid arthritis. Drugs Exp Clin Res. 1985;11:621\u20136.","journal-title":"Drugs Exp Clin Res"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03892-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-024-03892-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03892-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T16:35:30Z","timestamp":1738254930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-024-03892-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3892"],"URL":"https:\/\/doi.org\/10.1007\/s12185-024-03892-z","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"6 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yozo Nakazawa is an editor of International Journal of Hematology. All authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}